FDA Approvals: Hyzaar, Levemir, NovoLog-Novolin R
27th Oct 2005, 21:16 GMT
The FDA has approved a new dose for losartan plus hydrochlorothiazide combination tablets (Hyzaar), an expanded indication for insulin detemir subcutaneous injection (Levemir), and a new route of administration for insulin aspart and human insulin injections (NovoLog and Novolin R). Medscape Medical News Yael Waknine